إعلان
إعلان

INMB

INMB logo

INmune Bio Inc. Common stock

1.58
USD
برعاية
+0.02
+1.60%
٠٧ يناير, ١٥:٤٥ UTC -5
مغلق
exchange

بعد الإغلاق

1.58

0.00
0.00%

تقارير أرباح INMB

النسبة الإيجابية المفاجئة

INMB تفوق 15 من 27 آخر التقديرات.

56%

التقرير التالي

بيانات التقرير القادم
٢٥ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.24
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-40.00%

INmune Bio Inc. Common stock earnings per share and revenue

On ٣٠ أكتوبر ٢٠٢٥, INMB reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.33 USD, resulting in a 27.60% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.78% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an زيادة of 0.00% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, INmune Bio Inc. Common stock reported EPS of -$0.24, beating estimates by 27.6%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.78%, changed from $1.73 before the earnings release to $1.83 the day after.
The next earning report is scheduled for ٢٥ مارس ٢٠٢٦.
Based on 6 المحللين, INmune Bio Inc. Common stock is expected to report EPS of -$0.24 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان